DMI Leads Pharma Cloud Efficiency with AWS

The global pharmaceutical company faced challenges in improving customer experience while reducing operational costs. Existing IT projects were failing, and the company lacked the necessary skill sets for a user-centric approach. The need for a shared enterprise CI/CD solution and the push to go cloud-native added to the complexity. Key issues included upgrading web applications for clinical trial information, improving legacy application flexibility with AWS, tracking shipments globally, and migrating applications from Heroku to AWS.

DMI partnered with the pharmaceutical company to create a new digital strategy and undergo a complete business and technology transformation with AWS. A Digital Design Center was established, focusing on design-centric digital projects. The company’s redundant and disparate applications were modernized using serverless technologies on AWS. DMI developed a centralized CI/CD pipeline, migrated Heroku applications to AWS, and built a unified dashboard to track global shipments. The new architecture optimized content delivery, reduced maintenance costs, and provided on-demand scalability.

DMI’s solutions led to a 70% reduction in application costs and a 30% reduction in Total Cost of Ownership (TCO). The centralized CI/CD pipeline allowed for faster and more secure code releases. The average customer online time decreased to three and a half minutes, resulting in a 75% time saving for customers. The AWS Cloud platform provided agility, enabling faster infrastructure deployment and improved performance. The pharmaceutical company now enjoys optimized costs, operational efficiency, and flexibility, preparing it for future technological advancements.